+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Tissue Banking Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 144 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5911898
The global tissue banking market size reached US$ 1.6 Billion in 2022. Looking forward, the market is expected to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.65% during 2022-2028.

Tissue banking refers to the process of collecting, preparing, and preserving transplantable human tissues for potential therapeutic uses. The tissues obtained are utilized in healing and replacing the affected or lost tissues of the patients. They are also used to repair damaged heart muscles, treat spinal cord injuries, and heal skin from severe burns. At present, advancements in clinical trials and biomedical research are contributing to the demand for tissue preservation and banking across the globe.

Tissue Banking Market Trends

The coronavirus disease (COVID-19) pandemic has caused several deaths globally. As a result, researchers are relying on tissue banks to collect tissue specimens, understand cellular responses and the biological impact of infection and identify new therapeutic interventions and prevention strategies. Apart from this, the growing diagnosis of new diseases is escalating the demand for tissue banking in drug discovery. Moreover, the increasing prevalence of chronic diseases is positively influencing the adoption of tissue banks for the transplantation of bones, tendons, corneas, heart valves, and skin. Additionally, the rising geriatric population, in confluence with the growing number of individuals undergoing surgical interventions, is increasing the use of human tissue allografts across the globe. These tissues are used to repair limbs, relieve pain, and improve patients' life quality. Furthermore, the emerging trend of cosmetic surgeries on account of inflating disposable income and the growing consciousness among individuals about physical appearances is driving the market. Besides this, tissue banks can reduce the risk of bacterial and fungal contamination of tissues by using aseptic surgical techniques, equipment and supplies while processing and storing the tissue from the donor. This, in confluence with rising concerns about cross-infection, is creating a positive market outlook.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global tissue banking market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, application and tissue type.

Breakup by Product:

  • Equipment
  • Cryopreservation Equipment
  • Thawing Equipment
  • Quality Control Equipment
  • Media and Consumables

Breakup by Application:

  • Therapeutics
  • Medical Research

Breakup by Tissue Type:

  • Cardiovascular Tissue
  • Lung Tissue
  • Kidney Tissue
  • Pancreas Tissue
  • Liver Tissue
  • Eye Tissue

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).

Key Questions Answered in This Report

1. What was the size of the global tissue banking market in 2022?
2. What is the expected growth rate of the global tissue banking market during 2023-2028?
3. What are the key factors driving the global tissue banking market?
4. What has been the impact of COVID-19 on the global tissue banking market?
5. What is the breakup of the global tissue banking market based on the product?
6. What is the breakup of the global tissue banking market based on the application?
7. What is the breakup of the global tissue banking market based on the tissue type?
8. What are the key regions in the global tissue banking market?
9. Who are the key players/companies in the global tissue banking market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Tissue Banking Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Equipment
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Cryopreservation Equipment
6.1.2.2 Thawing Equipment
6.1.2.3 Quality Control Equipment
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Media and Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Medical Research
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Tissue Type
8.1 Cardiovascular Tissue
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Tissue
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Kidney Tissue
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Pancreas Tissue
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Liver Tissue
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Eye Tissue
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AMS Biotechnology
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Beckman Coulter Inc. (Danaher Corporation)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Bio-Rad Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Brooks Life Sciences Inc. (Brooks Automation Inc.)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Eppendorf AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 PHC Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 QIAGEN N.V.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sartorius AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Taylor-Wharton
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 VWR International LLC (Avantor Inc)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio

Companies Mentioned

  • AMS Biotechnology
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • Brooks Life Sciences Inc. (Brooks Automation Inc.)
  • Eppendorf AG
  • Merck KGaA
  • PHC Corporation
  • QIAGEN N.V.
  • Sartorius AG
  • Taylor-Wharton
  • Thermo Fisher Scientific Inc.
  • VWR International LLC (Avantor Inc)

Methodology

Loading
LOADING...

Table Information